Protein Signatures to Distinguish Aggressive from Indolent Prostate Cancer
Ontology highlight
ABSTRACT: We performed a mass spectrometry-based proteomic analysis of normal and malignant prostate tissues from 22 men who underwent surgery for prostate cancer. Prostate cancer samples included Grade Groups (3 to 5), with 8 patients experiencing recurrence and 14 without evidence of recurrence with a mean of 6.8 years of follow-up.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Prostate Gland
DISEASE(S): Prostate Cancer
SUBMITTER:
Sharon Pitteri
LAB HEAD: Sharon Pitteri
PROVIDER: PXD028118 | Pride | 2022-05-04
REPOSITORIES: Pride
ACCESS DATA